140 related articles for article (PubMed ID: 11013012)
21. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
[TBL] [Abstract][Full Text] [Related]
22. C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry.
Werfel T; Oppermann M; Begemann G; Götze O; Zwirner J
Arch Dermatol Res; 1997 Jan; 289(2):83-6. PubMed ID: 9049041
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59.
Mizuno M; Nishikawa K; Morgan BP; Matsuo S
Clin Exp Immunol; 2000 Feb; 119(2):368-75. PubMed ID: 10632677
[TBL] [Abstract][Full Text] [Related]
24. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells.
Wetsel RA
Immunol Lett; 1995 Jan; 44(2-3):183-7. PubMed ID: 7797249
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
[TBL] [Abstract][Full Text] [Related]
26. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation.
Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J
Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263
[TBL] [Abstract][Full Text] [Related]
27. Expression and induction of anaphylatoxin C5a receptors in the rat liver.
Schlaf G; Schmitz M; Rothermel E; Jungermann K; Schieferdecker HL; Götze O
Histol Histopathol; 2003 Jan; 18(1):299-308. PubMed ID: 12507307
[TBL] [Abstract][Full Text] [Related]
28. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.
Kola A; Baensch M; Bautsch W; Hennecke M; Klos A; Casaretto M; Köhl J
Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320
[TBL] [Abstract][Full Text] [Related]
29. Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor.
Farzan M; Schnitzler CE; Vasilieva N; Leung D; Kuhn J; Gerard C; Gerard NP; Choe H
J Exp Med; 2001 May; 193(9):1059-66. PubMed ID: 11342590
[TBL] [Abstract][Full Text] [Related]
30. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
31. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
Monk PN; Barker MD; Partridge LJ; Pease JE
J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
[TBL] [Abstract][Full Text] [Related]
32. Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease.
Farkas I; Takahashi M; Fukuda A; Yamamoto N; Akatsu H; Baranyi L; Tateyama H; Yamamoto T; Okada N; Okada H
J Immunol; 2003 Jun; 170(11):5764-71. PubMed ID: 12759460
[TBL] [Abstract][Full Text] [Related]
33. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting the C5-C5a receptor axis.
Woodruff TM; Nandakumar KS; Tedesco F
Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
[TBL] [Abstract][Full Text] [Related]
35. cDNA cloning and characterization of rat C5a anaphylatoxin receptor.
Akatsu H; Miwa T; Sakurada C; Fukuoka Y; Ember JA; Yamamoto T; Hugli TE; Okada H
Microbiol Immunol; 1997; 41(7):575-80. PubMed ID: 9272704
[TBL] [Abstract][Full Text] [Related]
36. Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain.
Naik N; Giannini E; Brouchon L; Boulay F
J Cell Sci; 1997 Oct; 110 ( Pt 19)():2381-90. PubMed ID: 9410877
[TBL] [Abstract][Full Text] [Related]
37. IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines.
Burg M; Martin U; Rheinheimer C; Köhl J; Bautsch W; Böttger EC; Klos A
J Immunol; 1995 Nov; 155(9):4419-26. PubMed ID: 7594603
[TBL] [Abstract][Full Text] [Related]
38. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke.
Floreani AA; Heires AJ; Welniak LA; Miller-Lindholm A; Clark-Pierce L; Rennard SI; Morgan EL; Sanderson SD
J Immunol; 1998 May; 160(10):5073-81. PubMed ID: 9590258
[TBL] [Abstract][Full Text] [Related]
39. Expression of the anaphylatoxin C5a receptor in non-myeloid cells.
Zwirner J; Fayyazi A; Götze O
Mol Immunol; 1999; 36(13-14):877-84. PubMed ID: 10698342
[TBL] [Abstract][Full Text] [Related]
40. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
Tardif M; Mery L; Brouchon L; Boulay F
J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
